Novel SDHD gene mutation (H102R) in a patient with metastatic cervical paraganglioma effectively treated by peptide receptor radionuclide therapy

J Clin Oncol. 2011 Nov 20;29(33):e812-5. doi: 10.1200/JCO.2011.36.2269. Epub 2011 Oct 24.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Female
  • Humans
  • Multimodal Imaging
  • Mutation*
  • Neoplasm Metastasis
  • Octreotide / analogs & derivatives*
  • Octreotide / therapeutic use
  • Paraganglioma / genetics*
  • Paraganglioma / radiotherapy
  • Paraganglioma / secondary
  • Positron-Emission Tomography
  • Succinate Dehydrogenase / genetics*
  • Tomography, X-Ray Computed
  • Uterine Cervical Neoplasms / genetics*
  • Uterine Cervical Neoplasms / pathology
  • Uterine Cervical Neoplasms / radiotherapy
  • Yttrium Radioisotopes / therapeutic use*

Substances

  • SDHD protein, human
  • Yttrium Radioisotopes
  • 90Y-octreotide, DOTA-Tyr(3)-
  • Succinate Dehydrogenase
  • Octreotide